{
    "title": "Britain's FTSE heads for third straight week of gains as AstraZeneca rises",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4499016/Britains-FTSE-heads-straight-week-gains-AstraZeneca-rises.html",
    "date": "2017-05-12",
    "keywords": [
        "drug",
        "percent",
        "trial",
        "stock",
        "cancer",
        "share",
        "index",
        "astrazeneca",
        "broker",
        "chip",
        "lung",
        "kepler",
        "cheuvreux",
        "exposure",
        "rbc",
        "kit",
        "friday",
        "track",
        "week",
        "gmt",
        "level",
        "gainer",
        "durvalumab",
        "risk",
        "death",
        "hope",
        "alternative",
        "pacific",
        "partner",
        "profitability",
        "pipeline",
        "progress",
        "peer",
        "shire",
        "support",
        "owner",
        "iag",
        "buy",
        "hold",
        "start",
        "year",
        "rask",
        "network",
        "transfer",
        "traffic",
        "head",
        "unit",
        "revenue",
        "seat",
        "life",
        "rating",
        "insurer",
        "release",
        "prospectus",
        "lifes",
        "merger",
        "asset",
        "management",
        "conviction",
        "insurance",
        "business",
        "value",
        "healthcare",
        "firm",
        "hikma",
        "approval",
        "advair",
        "target",
        "trading",
        "flat",
        "percentage",
        "catherine"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}